NCT07766161NARecruiting
Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression
University of Michigan
Start Date
7/29/2026
Completion Date
5/1/2027
Summary
The proposed study is an open-label trial of Re-Timer® wearable morning bright light therapy for postpartum depression. The study is focused on evaluating the feasibility, acceptability, and implementation context of morning Bright Light Treatment (mBLT) for postpartum depression.
Detailed Description
This study will test a consumer health light therapy device (Re-Timer)
Eligibility Criteria
Age Range: 18 years to No maximum
Inclusion Criteria:
1. ≤ 6 months postpartum
2. EPDS score \>10
Exclusion Criteria:
1. Current or past-year substance use disorder
2. Lifetime history of bipolar disorder or psychotic disorder
3. Active suicidal intent
4. Retinal pathology or history of eye surgery
5. Current use of photosensitizing medications
6. Untreated sleep-disordered breathing, untreated restless legs syndrome, or narcolepsy
7. Psychotherapy or psychotropic medications started/dose changed in past month (psychotherapy started and/or current medication at stable dose ≥ 4 weeks are permitted)
8. Medical conditions contraindicated for mBLT (e.g., epilepsy/seizures)
Interventions
DEVICE
Light therapy
Conditions
Postpartum Depression (PPD)
Locations
University of Michigan
Ann Arbor, Michigan 48109
United States